155 related articles for article (PubMed ID: 8362259)
1. Recovery of antithrombin III in patients undergoing orthotopic liver transplantation after administration of an antithrombin III concentrate.
Scherer RU; Gödde S; Giebler RM; Schmutzler MJ; Erhard J; Kox WJ
Semin Thromb Hemost; 1993; 19(3):309-10. PubMed ID: 8362259
[No Abstract] [Full Text] [Related]
2. Antithrombin III replacement in orthotopic liver transplantation.
Coccheri S; Palareti G
Semin Thromb Hemost; 1993; 19(3):268-72. PubMed ID: 8362256
[No Abstract] [Full Text] [Related]
3. Lack of correction of acquired heparin cofactor II deficiency in patients with liver failure after successful orthotopic liver transplantation.
Toulon P; Ledjev I; Ozier Y; Garnier JF; Houssin D
Thromb Haemost; 1992 Aug; 68(2):230-1. PubMed ID: 1412172
[No Abstract] [Full Text] [Related]
4. [Substitution therapy with antithrombin III in orthotopic liver transplantation: possible effect on hemorrhage reduction].
Baudo F; Caimi MT; Redaelli R; Cattaneo D; De Gasperi A; Belli L; de Cataldo F
Haematologica; 1990; 75 Suppl 2():41-9. PubMed ID: 2387550
[No Abstract] [Full Text] [Related]
5. Substitution of antithrombin III.
Breddin HK; Kirchmaier CM
Wien Klin Wochenschr; 1984 Dec; 96(24):875-9. PubMed ID: 6528616
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin III infusion in patients undergoing peritoneovenous shunt operation: failure in the prevention of disseminated intravascular coagulation.
Büller HR; ten Cate JW
Thromb Haemost; 1983 Apr; 49(2):128-31. PubMed ID: 6868009
[TBL] [Abstract][Full Text] [Related]
7. [Anti-coagulant therapy--antithrombin III].
Tsuji H
Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
[TBL] [Abstract][Full Text] [Related]
8. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin deficiency in special clinical syndromes--Part II: trauma/burns.
Penner J
Semin Hematol; 1995 Oct; 32(4 Suppl 2):42-7; discussion 48. PubMed ID: 8821209
[No Abstract] [Full Text] [Related]
10. [Three families with hereditary antithrombin III deficiency: the use of antithrombin III concentrate in one of the patients through the course of mastectomy (author's transl)].
Hirasawa Y; Hayashi M; Nagaoka T; Kuto F; Tokuhiro H
Nihon Ketsueki Gakkai Zasshi; 1981 May; 44(3):683-9. PubMed ID: 7331701
[No Abstract] [Full Text] [Related]
11. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
[TBL] [Abstract][Full Text] [Related]
12. Thrombophilia with a combination of antithrombin III and factor XII deficiency.
Maurin N; Schunkert H; Sieberth HG
Thromb Haemost; 1988 Aug; 60(1):127. PubMed ID: 3187943
[No Abstract] [Full Text] [Related]
13. [Significance of antithrombin III in clinical liver transplantations].
Lohse W; Winkler H; Wolff H
Zentralbl Chir; 1985; 110(13):803-10. PubMed ID: 3898652
[TBL] [Abstract][Full Text] [Related]
14. Treatment with AT III concentrates in hereditary and acquired AT III deficiency.
Gromnica-Ihle E; Ziemer S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):307-13. PubMed ID: 2465221
[TBL] [Abstract][Full Text] [Related]
15. Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease.
Peres E; Kintzel P; Dansey R; Baynes R; Abidi M; Klein J; Ibrahim RB; Abella E
Blood Coagul Fibrinolysis; 2008 Apr; 19(3):203-7. PubMed ID: 18388499
[TBL] [Abstract][Full Text] [Related]
16. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
Aibiki M; Fukuoka N; Nishiyama T; Maekawa S; Shirakawa Y
Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
[TBL] [Abstract][Full Text] [Related]
17. Replacement therapy in patients with hereditary antithrombin III deficiency.
Menache D
Semin Hematol; 1991 Jan; 28(1):31-8. PubMed ID: 2017690
[No Abstract] [Full Text] [Related]
18. [Antithrombin III in the Senegalese diabetic].
Thiam D; Belem WC; Ndiaye MF; Diakhate L; Sow AM
Dakar Med; 1990; 35(2):193-7. PubMed ID: 2135794
[TBL] [Abstract][Full Text] [Related]
19. The response of antithrombin III activity after supplementation decreases in proportion to the severity of sepsis and liver dysfunction.
Hayakawa M; Sawamura A; Yanagida Y; Sugano M; Hoshino H; Gando S
Shock; 2008 Dec; 30(6):649-52. PubMed ID: 18496242
[TBL] [Abstract][Full Text] [Related]
20. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders].
Schramm W
Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
